Quality of life in patients with lung cancer

Julia DiGiovanni; Marko Popovic; Edward Chow; David Cella; Jennifer L. Beaumont; Jasmine Nguyen; Dominic Chu; Anthony Adili; Natalie Pulenzas; Breanne Lechner; Henry Lam; Andrew Bottomley

Quality of life in patients with lung cancer

Julia DiGiovanni, Marko Popovic, Edward Chow^*, David Cella, Jennifer L. Beaumont, Jasmine Nguyen, Dominic Chu, Anthony Adili, Natalie Pulenzas, Breanne Lechner, Henry Lam, Andrew Bottomley

^*Corresponding author for this work

Medical Social Sciences

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

In this chapter we compare the development, characteristics, validity and reliability of two widely used quality of life (QOL) assessment tools in lung cancer: the EORTC QLQLC13 and the FACT-L. The authors found that both questionnaires were developed from input of patients and health care professionals. The QLQ-LC13 is a 13-item instrument that assesses coughing, hemoptysis, dyspnea and pain and the side effects of treatment. Two international field studies have concluded that the QLQ-LC13 is clinically valid and useful. Conversely, the FACT-L assesses general QOL and seven lung cancer-specific items, such as shortness of breath, weight loss, cough, and appetite. In a study of 116 lung cancer patients, the FACT-L was found to have a good internal consistency, reliability, and sensitivity to changes in performance status. Ultimately, both the EORTC QLQ-LC13 and the FACT-L have been sufficiently validated; as such, decision-making should depend on the needs of the investigation.

Original language	English (US)
Title of host publication	Cancer
Subtitle of host publication	Treatment, Decision Making and Quality of Life
Publisher	Nova Science Publishers, Inc.
Pages	79-92
Number of pages	14
ISBN (Electronic)	9781634838825
ISBN (Print)	9781634838634
State	Published - Jan 1 2016

ASJC Scopus subject areas

Medicine(all)

Access to Document

Fingerprint Dive into the research topics of 'Quality of life in patients with lung cancer'. Together they form a unique fingerprint.

Cite this

@inbook{1e79c4923df84115b363983213969804,

title = "Quality of life in patients with lung cancer",

abstract = "In this chapter we compare the development, characteristics, validity and reliability of two widely used quality of life (QOL) assessment tools in lung cancer: the EORTC QLQLC13 and the FACT-L. The authors found that both questionnaires were developed from input of patients and health care professionals. The QLQ-LC13 is a 13-item instrument that assesses coughing, hemoptysis, dyspnea and pain and the side effects of treatment. Two international field studies have concluded that the QLQ-LC13 is clinically valid and useful. Conversely, the FACT-L assesses general QOL and seven lung cancer-specific items, such as shortness of breath, weight loss, cough, and appetite. In a study of 116 lung cancer patients, the FACT-L was found to have a good internal consistency, reliability, and sensitivity to changes in performance status. Ultimately, both the EORTC QLQ-LC13 and the FACT-L have been sufficiently validated; as such, decision-making should depend on the needs of the investigation.",

author = "Julia DiGiovanni and Marko Popovic and Edward Chow and David Cella and Beaumont, {Jennifer L.} and Jasmine Nguyen and Dominic Chu and Anthony Adili and Natalie Pulenzas and Breanne Lechner and Henry Lam and Andrew Bottomley",

year = "2016",

month = jan,

day = "1",

language = "English (US)",

isbn = "9781634838634",

pages = "79--92",

booktitle = "Cancer",

publisher = "Nova Science Publishers, Inc.",

}

Quality of life in patients with lung cancer. / DiGiovanni, Julia; Popovic, Marko; Chow, Edward; Cella, David; Beaumont, Jennifer L.; Nguyen, Jasmine; Chu, Dominic; Adili, Anthony; Pulenzas, Natalie; Lechner, Breanne; Lam, Henry; Bottomley, Andrew.

Cancer: Treatment, Decision Making and Quality of Life. Nova Science Publishers, Inc., 2016. p. 79-92.

Research output: Chapter in Book/Report/Conference proceeding › Chapter

TY - CHAP

T1 - Quality of life in patients with lung cancer

AU - DiGiovanni, Julia

AU - Popovic, Marko

AU - Chow, Edward

AU - Cella, David

AU - Beaumont, Jennifer L.

AU - Nguyen, Jasmine

AU - Chu, Dominic

AU - Adili, Anthony

AU - Pulenzas, Natalie

AU - Lechner, Breanne

AU - Lam, Henry

AU - Bottomley, Andrew

PY - 2016/1/1

Y1 - 2016/1/1

N2 - In this chapter we compare the development, characteristics, validity and reliability of two widely used quality of life (QOL) assessment tools in lung cancer: the EORTC QLQLC13 and the FACT-L. The authors found that both questionnaires were developed from input of patients and health care professionals. The QLQ-LC13 is a 13-item instrument that assesses coughing, hemoptysis, dyspnea and pain and the side effects of treatment. Two international field studies have concluded that the QLQ-LC13 is clinically valid and useful. Conversely, the FACT-L assesses general QOL and seven lung cancer-specific items, such as shortness of breath, weight loss, cough, and appetite. In a study of 116 lung cancer patients, the FACT-L was found to have a good internal consistency, reliability, and sensitivity to changes in performance status. Ultimately, both the EORTC QLQ-LC13 and the FACT-L have been sufficiently validated; as such, decision-making should depend on the needs of the investigation.

AB - In this chapter we compare the development, characteristics, validity and reliability of two widely used quality of life (QOL) assessment tools in lung cancer: the EORTC QLQLC13 and the FACT-L. The authors found that both questionnaires were developed from input of patients and health care professionals. The QLQ-LC13 is a 13-item instrument that assesses coughing, hemoptysis, dyspnea and pain and the side effects of treatment. Two international field studies have concluded that the QLQ-LC13 is clinically valid and useful. Conversely, the FACT-L assesses general QOL and seven lung cancer-specific items, such as shortness of breath, weight loss, cough, and appetite. In a study of 116 lung cancer patients, the FACT-L was found to have a good internal consistency, reliability, and sensitivity to changes in performance status. Ultimately, both the EORTC QLQ-LC13 and the FACT-L have been sufficiently validated; as such, decision-making should depend on the needs of the investigation.

UR - http://www.scopus.com/inward/record.url?scp=85060483615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060483615&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:85060483615

SN - 9781634838634

SP - 79

EP - 92

BT - Cancer

PB - Nova Science Publishers, Inc.

ER -